PMC:7228307 / 2959-3141 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T32","span":{"begin":48,"end":51},"obj":"http://purl.obolibrary.org/obo/CLO_0050884"}],"text":"$45.6 billion in sales, placing them in the top ten drugs globally.2 MAb development is expanding rapidly with over 100 mAbs approved for clinical use or in late‐stage clinical trial"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T9","span":{"begin":17,"end":22},"obj":"Chemical"},{"id":"T10","span":{"begin":52,"end":57},"obj":"Chemical"}],"attributes":[{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_24866"},{"id":"A10","pred":"chebi_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"$45.6 billion in sales, placing them in the top ten drugs globally.2 MAb development is expanding rapidly with over 100 mAbs approved for clinical use or in late‐stage clinical trial"}